UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058136
Receipt number R000066373
Scientific Title Clinical Utility of Image-Enhanced Endoscopy in Artificial Intelligence-Assisted Endoscopic Diagnosis
Date of disclosure of the study information 2025/06/13
Last modified on 2025/06/10 10:36:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Utility of Image-Enhanced Endoscopy in Artificial Intelligence-Assisted Endoscopic Diagnosis

Acronym

Artificial Intelligence with Linked Color Imaging for Optimal Lesion Recognition/ AI-Color

Scientific Title

Clinical Utility of Image-Enhanced Endoscopy in Artificial Intelligence-Assisted Endoscopic Diagnosis

Scientific Title:Acronym

Clinical Utility of Image-Enhanced Endoscopy in Artificial Intelligence-Assisted Endoscopic Diagnosis

Region

Japan


Condition

Condition

Early gastric neoplasm

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study aims to compare the utility of AI-assisted gastric endoscopy using white light imaging (WLI) and that using linked color imaging (LCI) in the detection of gastric neoplasms.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

This study aims to assess whether LCI significantly reduces the number of false-positive detections while maintaining a tumor detection rate of over 95%.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

During the process of gastric observation, the first upper gastrointestinal endoscopy will be performed using AI-assisted white light imaging (WLI-AI group), followed by a second endoscopic examination using AI-assisted linked color imaging (LCI-AI group).

Interventions/Control_2

During the process of gastric observation, the first upper gastrointestinal endoscopy will be performed using AI-assisted linked color imaging (LCI-AI group), followed by a second endoscopic examination using AI-assisted white light imaging (WLI-AI group).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with upper gastrointestinal tumors and scheduled to undergo upper gastrointestinal endoscopy and/or treatment under sedation

Male or female patients aged 18 years or older

Patients who have provided written informed consent

Key exclusion criteria

Patients with heart failure or unstable hemodynamics in whom sedation during the procedure is considered unsafe

Patients for whom endoscopy is generally contraindicated (e.g., those with ileus, gastrointestinal perforation, severe respiratory disease, or severe cardiovascular disease)

Patients deemed unsuitable for participation in this study due to serious comorbidities or other medical reasons

Target sample size

36


Research contact person

Name of lead principal investigator

1st name MINODA
Middle name
Last name YOSUKE

Organization

Kyushu University Hospital

Division name

Department of Medicine and Bioregulatory Science

Zip code

8518582

Address

maidashi3-1-1, Fukuoka, Japan

TEL

0926425286

Email

minoda.yosuke.633@m.kyushu-u.ac.jp


Public contact

Name of contact person

1st name Minoda
Middle name
Last name Yosuke

Organization

Kyushu University Hospital

Division name

Department of Medicine and Bioregulatory Science

Zip code

851-8582

Address

3-1-1 Maidashi, Fukuoka, Japan

TEL

0926425286

Homepage URL


Email

minoda.yosuke.633@m.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu Univesity

Institute

Department

Personal name



Funding Source

Organization

n/a

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyushu University

Address

3-1-1 Maidashi, Fukuoka, Japan

Tel

0926425286

Email

minoda.yosuke.633@m.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 06 Month 10 Day

Date of IRB


Anticipated trial start date

2025 Year 06 Month 16 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 06 Month 10 Day

Last modified on

2025 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066373